Idorsia Ltd (IDRSF) TRYVIO Investor Q&A Webcast And Conference Call (Transcript)
Source: SeekingAlpha
2025-09-08 12:30:22 ET
Idorsia Ltd (IDRSF) TRYVIO Investor Q&A Webcast and Conference Call
Company Participants
Srishti Gupta - CEO & Executive Director
Martine Clozel - Executive VP, Chief Scientific Officer & Head of Research
Alessandro Maresta
Michael Moye - President/GM of Idorsia US
Julien Gander - Senior VP, Executive VP, Chief Legal and Corporate Development Officer & Company Secretary ...
Read the full article on Seeking Alpha
For further details see:
Idorsia Ltd (IDRSF) TRYVIO Investor Q&A Webcast And Conference Call (Transcript)
Idorsia Ltd Registered Shares
NASDAQ: IDRSF
IDRSF Trading
0.0% G/L:
$5.16 Last:
1,502 Volume:
$5.16 Open:
IDRSF Latest News
January 05, 2026 11:45:00 am
Idorsia's daridorexant in women during menopausal transition age with insomnia
December 10, 2025 01:00:00 am
New Hypertension publication underscores aprocitentan's potential in managing hypertension patients with CKD
November 10, 2025 11:45:00 am
Idorsia's aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
November 05, 2025 11:45:00 am
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
